[On extubation, residual curarization, and their circumstances].
Ortiz-Gómez
J R
JR
Fabregat-López
J
J
D000762:Anesthesia Recovery Period; D019090:Case Management; D003221:Confusion / Q000139:chemically induced / Q000517:prevention & control; D004576:Electromyography; D006801:Humans; D019148:Neuromuscular Blockade / Q000009:adverse effects* / Q000379:methods; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D010243:Paralysis / Q000139:chemically induced / Q000517:prevention & control; D011015:Pneumonia, Aspiration / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control; D011183:Postoperative Complications / Q000139:chemically induced* / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D020127:Recovery of Function; D000077122:Sugammadex; D015300:Ventilator Weaning / Q000009:adverse effects / Q000523:psychology; D047408:gamma-Cyclodextrins / Q000627:therapeutic use
D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex